RxDoctor Payments Data

William Morris

Cardiovascular Disease · Buffalo, NYNPI 1538127923

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.7%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Abbott at 42.8% of the total. Reporting peaked in 2019 at $7,633 and has fallen 97.9% since, to $162 in 2022.

$11,526in general payments, 2019–2025

Across 255 payments — averaging $45.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$5K
  • Boston Scientific$3K
  • Edwards Lifesciences$2K
  • Abiomed$868
  • Inari Medical, Inc.$133
  • Medtronic$112
  • plus $231 from 9 others

What the payments were for

  • Consulting fees$6,30055%
  • Speaking & faculty fees$2,01317%
  • Food & beverage$3,21328%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,526 in reported general payments places this provider in the 85th percentile of 2,302 cardiovascular disease providers in New York.

See all cardiovascular disease providers in New York →

Other cardiovascular disease in Buffalo

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →